Related Experiment Videos
Management of Hypertension among Patients with Coronary Heart Disease
Oladipupo Olafiranye1, Ferdinand Zizi, Perry Brimah
1Brooklyn Health Disparities Center, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY 11203, USA.
Insights
Hypertension significantly increases coronary heart disease (CHD) risk by accelerating atherosclerosis and causing myocardial ischemia. Optimal blood pressure (BP) control is crucial for reducing these cardiovascular risks in patients with hypertension.
Area of Science:
- Cardiology
- Hypertension Research
- Atherosclerosis Studies
Background:
- Hypertension is a primary driver of coronary heart disease (CHD), accelerating atherosclerosis and increasing the risk of acute coronary events.
- Elevated blood pressure (BP) can lead to myocardial ischemia, even in the absence of diagnosed CHD.
- Optimal BP control is recognized as a key strategy for mitigating cardiovascular risks associated with hypertension.
Purpose of the Study:
- To examine the evidence and mechanisms linking hypertension and CHD.
- To discuss current treatment options and therapeutic goals for managing hypertension in patients with CHD.
- To align with guidelines from the seventh Joint National Committee (JNC 7) and the American Heart Association, while anticipating future recommendations.
Main Methods:
- Review of existing scientific evidence on hypertension and CHD.
- Analysis of the pathophysiological mechanisms connecting elevated BP to cardiovascular events.
- Discussion of antihypertensive agents and target BP goals based on current guidelines.
Main Results:
- Hypertension demonstrably accelerates atherosclerosis and can precipitate acute coronary events.
- Myocardial ischemia can occur due to hypertension independently of established CHD.
- The optimal choice of antihypertensive agents and target BP for patients with CHD remains a subject of ongoing debate.
Conclusions:
- Effective BP management is essential for reducing hypertension-related cardiovascular risks, including CHD.
- Current therapeutic strategies aim to align with JNC 7 and AHA recommendations.
- Anticipation of updated guidelines (JNC 8) suggests evolving approaches to hypertension management in CHD patients.
Abstract:
Evidence suggests that coronary heart disease (CHD) is the most common outcome of hypertension. Hypertension accelerates the development of atherosclerosis, and sustained elevation of blood pressure (BP) can destabilize vascular lesions and precipitate acute coronary events. Hypertension can cause myocardial ischemia in the absence of CHD. These cardiovascular risks attributed to hypertension can be reduced by optimal BP control. Although several antihypertensive agents exist, the choice of agent and the appropriate target BP for patients with CHD remain controversial. In this succinct paper, we examine the evidence and the mechanisms for the linkage between hypertension and CHD and we discuss the treatment options and the goals of therapy that are consistent with the report of the seventh Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) and American Heart Association scientific statement. We anticipate changes in the recommendations of the forthcoming JNC 8.
Related Concept Videos
Heart Failure V: Medical Management
Angina IV: Management
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease IV: Preventive Measures